MeadJohnson美赞臣品牌怎么样 申请店铺

我要投票 MeadJohnson美赞臣在婴儿奶粉行业中的票数:1481 更新时间:2026-01-26
美赞臣公司创立于1905年,创始人为爱德华?美赞臣。至今已有百年历史,是世界上生产营养品的大型跨国企业,堪称世界营养权威。全球拥有雇员约5300人。公司总部位于美国印地安纳州的埃文思威尔。美赞臣公司在

外推网助力MeadJohnson美赞臣品牌出海!将品牌入驻外推网,定制MeadJohnson美赞臣品牌推广信息,可以显著提高MeadJohnson美赞臣产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

MeadJohnson美赞臣怎么样

美赞臣公司创立于1905年,创始人为爱德华?美赞臣。至今已有百年历史,是世界上生产营养品的大型跨国企业,堪称世界营养权威。全球拥有雇员约5300人。公司总部位于美国印地安纳州的埃文思威尔。美赞臣公司在全球拥有7个生产基地,营养产品行销50多个国家和地区,所经营的婴幼儿奶粉是全球市场的领导品牌。

美赞臣全球总裁及首席执行官StephenW.Golsby先生曾说过:“我们认真而严肃地肩负起责任,致力为婴儿和儿童提供一生中最好的开始,而我们所做出的贡献已赢得了全球营养专家和家长们的信赖和尊重。”

为帮助孩子们的成长创造一个良好的开始,公司不断进行产品的研发创新。美赞臣极具口碑的首创产品包括:Dextri-Maltose糊精麦芽糖,第一种在美国经临床试验,由医师推荐的婴儿食品:Pablum,第一种添加了维生素的速溶谷类食品及近年来在中国市场推出的添加DHA、ARA的系列A+婴幼儿配方奶粉。一个多世纪以来,美赞臣一直全心全意,致力于“创立值得信赖的营养品品牌和产品,为婴儿和儿童提供一生中最好的开始”,在全力以赴的营养科学研究中,全球科研成果不断涌现,并被应用到美赞臣的配方奶粉中,为婴儿和儿童成长的每一步提供优质的营养。

美赞臣中国:

美赞臣营养品(中国)有限公司的生产基地位于广州经济技术开发区东基夏园路,占地面积六万平方米,生产设备均为世界领先水平。销售网络辐射全国29个省份,自治区和直辖市。

秉承“为婴儿和儿童提供一生中最好的开始”的一贯宗旨,美赞臣营养品(中国)有限公司致力为中国消费者服务,不但生产从孕期到儿童期的优质营养品,同时致力于促进中国婴幼儿营养保健事业的发展,积极开展各种育婴普及活动,向年轻父母宣传国际领先的早教理念,为中国的宝宝及家长提供美赞臣世界级营养专家的呵护与关怀。

目前,美赞臣中国公司已经建立起了一个“满腔热情、团结高效、务实求新”的团队,这是公司最宝贵的财富,也是美赞臣在全球一直占据领导地位的原动力与最大资本。


Mead Johnson was founded in 1905 by Edward Mead Johnson. With a history of 100 years, it is a large-scale multinational enterprise that produces nutrition products in the world, and it can be called the world's nutrition authority. Around 5300 employees worldwide. The company is headquartered in Evansville, Indiana, USA. Mead Johnson has 7 production bases in the world, more than 50 countries and regions marketing nutritional products, and its infant milk powder is the leading brand in the global market. Mr. Stephen W. golsby, global president and CEO of Mead Johnson, once said: "we take our responsibilities seriously and seriously to provide infants and children with the best start in life, and our contribution has won the trust and respect of global nutrition experts and parents." In order to help children's growth create a good start, the company continues to carry out product research and development innovation. Mjn's well-known first products include dextri maltose dextrin maltose, the first infant food recommended by doctors after clinical trials in the United States, pablum, the first instant cereal food with vitamins, and a series of a + infant formula milk powder with DHA and Ara launched in China in recent years. For more than a century, Mead Johnson has been committed to "creating reliable nutrition brands and products, providing the best start in life for infants and children". In the full-scale nutrition scientific research, the global scientific research results continue to emerge, and are applied to Mead Johnson's formula, providing high-quality nutrition for every step of the growth of infants and children. Mead Johnson China: the production base of Mead Johnson nutritionals (China) Co., Ltd. is located in Xiayuan Road, Dongji, Guangzhou Economic and Technological Development Zone, covering an area of 60000 square meters. The production equipment is the world's leading level. The sales network covers 29 provinces, autonomous regions and municipalities directly under the central government. Adhering to the consistent purpose of "providing the best start in life for infants and children", Mead Johnson nutritionals (China) Co., Ltd. is committed to serving Chinese consumers, not only producing high-quality nutritious products from pregnancy to childhood, but also promoting the development of infant nutrition and health care in China, actively carrying out various infant education popularization activities, and promoting the world's leading The concept of early education provides the care and care of Mead Johnson's world-class nutrition experts for Chinese babies and parents. At present, Mead Johnson China has established a team full of enthusiasm, unity, efficiency, pragmatism and innovation, which is the most valuable wealth of the company, as well as the driving force and the largest capital of Mead Johnson's leading position in the world.

本文链接: https://brand.waitui.com/fa0db3938.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

国产创新药里程碑款频获兑现 行业向可持续收益模式转型

国家药监局最新数据显示,2025年我国批准上市的创新药达76个,创历史新高。同时,创新药对外授权交易总金额超过1300亿美元,授权交易数量超过150笔。近期,国产创新药企的里程碑款捷报频传,表明中国创新药研发的价值得到验证。然而,过去由于里程碑款兑现率较低,业内常有“一次性BD”的诟病。如今,随着里程碑款的持续落地,行业正向可持续收益模式转型。(证券时报)

33分钟前

多只理财产品业绩比较基准上限下调至不足3%

近期,农银理财、中邮理财、招银理财、上银理财等多家机构下调旗下理财产品业绩比较基准,部分产品最大降幅达100个基点。调整后,多数产品的业绩比较基准上限已不足3%,理财市场低收益新常态特征愈发凸显。受访专家表示,此次调整受市场利率环境变化与监管导向的驱动,后续业绩基准仍面临下行压力,但降幅会逐步收窄。(证券日报)

33分钟前

华泰证券:市场或逐步切向业绩修复方向

36氪获悉,华泰证券研报认为,上周A股市场在资金情绪分化下,小盘股涨幅居前,行业轮动持续,向后看,资金面的弹性及后续轮动方向是市场主要关注点。研报认为1月中旬以来,宽基ETF流出金额虽偏高,但考虑到险资等仍有增量、投资者存在套利需求,市场持续放量下,资金侧仍有接力动能。轮动方向或由主题逐步切往存在业绩印证的方向,历史复盘来看,业绩预告披露期内的,景气具备持续修复能力的行业通常具备一定超额收益,具体到本轮,景气修复的线索或主要集中在涨价链、高端制造及AI链中,结合拥挤度进一步考量,配置上可关注电力设备、基础化工、半导体设备等,适度增配周期型红利。

33分钟前

国泰君安国际:预期2025年度净利润为12.80亿至13.80亿港元之间,同比上升265%至293%

36氪获悉,国泰君安国际在港交所公告,预期本集团截至2025年12月31日止年度的净利润为12.80亿至13.80亿港元之间,较2024年净利润约3.51亿港元大幅飙升265%至293%。该预期增长的主要原因为本集团企业融资、财富管理、资产管理及交易及投资等核心业务收入全面大幅上升,其中股权融资及经纪业务表现尤为突出。

33分钟前

开年迎3家公司上市,北交所总市值逼近万亿元规模

2026年以来,北交所迎来科马材料、爱舍伦、国亮新材三家公司上市,同时还有美德乐、农大科技两家公司进入发行流程。当前北交所正成为服务创新型中小企业的重要阵地。截至1月23日,北交所上市公司达290家,总市值9670.53亿元,逼近万亿元大关。与此同时,北交所IPO审核正保持高频节奏,多家券商认为,在北交所市场制度改革深化背景下,预计后续IPO有望维持高速发行态势。(中证网)

33分钟前

本页详细列出关于MeadJohnson美赞臣的品牌信息,含品牌所属公司介绍,MeadJohnson美赞臣所处行业的品牌地位及优势。
咨询